Fukoku Mutual Life Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-551	Closed	-$251K	–	248
2025 Q3	$251K	Sell	551 -108	-16%	-$44K	0.02%	211
2025 Q2	$215K	Sell	659 -255	-28%	-$70.6K	0.01%	251
2025 Q1	$247K	Hold	914	–	–	0.02%	228
2024 Q4	$215K	Hold	914	–	–	0.02%	256
2024 Q3	$251K	Hold	914	–	–	0.02%	241
2024 Q2	$222K	Buy	+914	New	+$144K	0.02%	251
2023 Q1	–	Sell	-1,430	Closed	-$340K	–	257
2022 Q4	$340K	Hold	1,430	–	–	0.03%	176
2022 Q3	$286K	Sell	1,430 -150	-9%	-$28.6K	0.03%	204
2022 Q2	$230K	Hold	1,580	–	–	0.02%	241
2022 Q1	$258K	Hold	1,580	–	–	0.02%	249
2021 Q4	$268K	Buy	1,580 +50	+3%	+$9.29K	0.02%	244
2021 Q3	$289K	Buy	1,530 +230	+18%	+$43.1K	0.02%	238
2021 Q2	$220K	Hold	1,300	–	–	0.02%	259
2021 Q1	$184K	Hold	1,300	–	–	0.02%	256
2020 Q4	$169K	Hold	1,300	–	–	0.02%	259
2020 Q3	$189K	Buy	1,300 +200	+18%	+$28.4K	0.02%	232
2020 Q2	$163K	Hold	1,100	–	–	0.02%	235
2020 Q1	$120K	Hold	1,100	–	–	0.02%	233
2019 Q4	$127K	Buy	1,100 +300	+38%	+$29.9K	0.01%	275
2019 Q3	$64K	Hold	800	–	–	0.01%	298
2019 Q2	$58K	Buy	800 +100	+14%	+$7.67K	0.01%	301
2019 Q1	$65K	Hold	700	–	–	0.01%	285
2018 Q4	$51K	Buy	700 +200	+40%	+$15.4K	0.01%	294
2018 Q3	$44K	Hold	500	–	–	0.01%	305
2018 Q2	$49K	Buy	500 +100	+25%	+$9.92K	0.01%	297
2018 Q1	$48K	Hold	400	–	–	0.01%	292
2017 Q4	$51K	Buy	+400	New	+$50.3K	0.01%	286